Related Experiment Video
Updated: Aug 13, 2025

11:06
Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques
Published on: May 2, 2017
51.2K
Spontaneous neoplasms in captive red-bellied lemurs (Eulemur rubriventer)
Daniel F Barrantes Murillo1, Tatiane T Negrão Watanabe2
1Department of Pathobiology, Auburn University College of Veterinary Medicine, Auburn, Alabama, USA.
Journal of Comparative Pathology
|January 21, 2023
Summary
This study reports the first cases of osteosarcoma and hepatocellular carcinoma in red-bellied lemurs, a vulnerable primate species. These findings highlight the importance of monitoring neoplasia in lemur populations.
Area of Science:
- Veterinary Pathology
- Primate Oncology
- Conservation Medicine
Background:
- Red-bellied lemurs (Eulemur rubriventer) are vulnerable non-human primates endemic to Madagascar.
- Neoplasia descriptions in this species are rare, with only one prior report of hepatocellular adenoma.
Purpose of the Study:
- To document and characterize neoplasia in red-bellied lemurs.
- To contribute to the understanding of cancer in Strepsirrhini primates.
Main Methods:
- Retrieved prosimian cases from North Carolina State University's Anatomic Pathology Service (2010-2021).
- Identified and analyzed cases specifically involving the genus Eulemur and red-bellied lemurs.
- Histopathologically reviewed neoplastic lesions.
Main Results:
- Two of seven red-bellied lemur cases (28.57%) exhibited neoplasia.
- Identified hepatocellular carcinoma in a 25-year-old female and osteoblastic osteosarcoma of the clavicle in a 33-year-old female.
- Hepatocellular carcinoma is more common than adenoma in prosimians; osteosarcoma is rare in lemuriformes.
Conclusions:
- This study presents the first documented cases of osteosarcoma and hepatocellular carcinoma in red-bellied lemurs.
- Findings emphasize the need for further research into neoplasia prevalence and types in this vulnerable species.
- Contributes valuable data for conservation efforts and comparative oncology.

